Nephros, Inc. (NEPH) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, everyone, and welcome to the Nefrosync 4th Quarter 2025 Financial Results Conference. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star and then one on your touch-tone telephones. To withdraw your questions, you may press star and two. Please also note today's event is being recorded. At this time, I would like to turn the floor over to Kieran Smith, Investor Relations. Please go ahead. Thank you, Jamie, and good afternoon, everyone. This is Kieran Smith with TCG Advisory. Thank you all for participating in NEPHRO's fourth quarter and fiscal year 2025 conference call. Before we begin, I would like to caution that comments made during this conference call by management will contain forward-looking statements regarding the operations and future results of NEPHROs. I encourage you to review NEPHROs' filings with the Securities and Exchange Commission, including without limitation the company's forms 10-K and 10-Q, which identify specific factors that make those actual results or events differ materially from those described in the forward-looking statements. Factors that may affect the company's results include but are not limited to Nefros' ability to successfully, timely, and cost-effectively market and sell its products and service offerings, the rate of adoption of its products and services by hospitals and other healthcare providers, the success of its commercialization efforts, and the effect of existing and new regulatory requirements on Nefros' business and other economic and competitive factors. The contents of this conference ca...